Filing Details
- Accession Number:
- 0001104659-22-084315
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-29 17:01:37
- Reporting Period:
- 2022-07-27
- Accepted Time:
- 2022-07-29 17:01:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1736243 | Acurx Pharmaceuticals Inc. | ACXP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1271123 | P David Luci | C/O Acurx Pharmaceuticals, Inc., 259 Liberty Avenue Staten Island NY 10305 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-27 | 19,737 | $3.80 | 1,028,460 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants for Common Stock | Acquisiton | 2022-07-27 | 19,737 | $0.00 | 19,737 | $3.55 |
| Common Stock | Warrants for Common Stock | Acquisiton | 2022-07-27 | 19,737 | $0.00 | 19,737 | $3.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,737 | 2023-01-27 | 2024-01-27 | No | 4 | P | Direct |
| 19,737 | 2023-01-27 | 2028-01-27 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 15,083 | Indirect | By spouse |
| Common Stock | 35,000 | Indirect | By child |
Billionaire Hedge Funds
